Melatonin blunted the angiogenic activity in 3D colon cancer tumoroids by the reduction of endocan

Abstract

Background Complexity and heterogeneity of the tumor niche are closely associated with the failure of therapeutic protocols. Unfortunately, most data have been obtained from conventional 2D culture systems which are not completely comparable to in vivo microenvironments. Reconstructed 3D cultures composed of multiple cells are valid cell-based tumor models to recapitulate in vivo-like interaction between the cancer cells and stromal cells and the oncostatic properties of therapeutics. Here, we aimed to assess the tumoricidal properties of melatonin on close-to-real colon cancer tumoroids in in vitro conditions. Methods Using the hanging drop method, colon cancer tumoroids composed of three cell lines, including adenocarcinoma HT-29 cells, fibroblasts (HFFF2), and endothelial cells (HUVECs) at a ratio of 2: 1: 1, respectively were developed using 2.5% methylcellulose. Tumoroids were exposed to different concentrations of melatonin, from 0.005 to 0.8 mM and 4 to 10 mM, for 48 h. The survival rate was measured by MTT and LDH leakage assays. Protein levels of endocan and VEGF were assessed using western blotting. Using histological examination (H & E) staining, the integrity of cells within the tumoroid parenchyma was monitored. Results Despite the reduction of viability rate in lower doses, the structure of tumoroids remained unchanged. In contrast, treatment of tumoroids with higher doses of melatonin, 4 and 10 mM, led to disaggregation of cells and reduction of tumoroid diameter compared to the non-treated control tumoroids (p < 0.05). By increasing melatonin concentration from 4 to 10 mM, the number of necrotic cells increased. Data showed the significant suppression of endocan in melatonin-treated tumoroids related to the non-treated controls (p < 0.05). According to our data, melatonin in higher doses did not alter protein levels of VEGF (p > 0.05). Conclusions Melatonin can exert its tumoricidal properties on colon cancer tumoroids via the reduction of tumor cell viability and inhibition of the specific pro-angiogenesis factor.

Melatonin alleviates myocardial dysfunction through inhibition of endothelial‐to‐mesenchymal transition via the NF‐κB pathway

“…The current trend in new drug design involves the utilization of 3D organoids for discovering the effects of the drugs. Previous studies have demonstrated that the application of melatonin in 3D cultures presents considerable potential therapeutic efficacy for comprehending the antitumor effects aimed at blunting angiogenic activity 46 . Our data indicated that melatonin has the potential to restore endothelial function not only in in vitro experiments but also in EndMT‐induced VOs.…”

Insights on Three Dimensional Organoid Studies for Stem Cell Therapy in Regenerative Medicine

“…The promise that exists now is that cells cultivated in three-dimensional aggregates have the capacity to increase resistance to different cancer treatments. Recent research by Narmi et al in 2023, which discovered that using 3D culture is an efficient way to evaluate anticancer drugs, has supported this work [ 16 ]. Various priming techniques have been developed that aim to sensitize cells and get them ready for therapeutic treatment.…”

“…This provides a more representative platform for researching these methods [ 11 , 17 ]. In 2023 Narmi and colleagues discovered that the use of melatonin in three-dimensional culture has significant promise for comprehending the anti-tumour activity exhibited by melatonin in reaction to certain angiogenesis elements [ 16 ].…”

Regulation of cell fate by cell imprinting approach in vitro

“…It was stated that the 3D tumoroid system is a promising approach for the assessment of anti-cancer compounds as compared to the conventional 2D culture system and melatonin was able to significantly decrease the cohesion of tumor mass through the arrest of some angiogenesis agents such as endocan with simultaneous induction of necrotic variations. 45 …”